Bioinformatics developer (Location: Valencia/Belgrade/Remote)

Born from a mission to illuminate the path for patients with rare diseases, Centogene's journey began in 2006. Founded by Professor Arndt Rolfs in Rostock, Germany, the company emerged with a singular, powerful focus: to transform the landscape of genetic diagnostics. In a world where rare diseases often left individuals and families navigating a labyrinth of uncertainty, Centogene set out to provide clear, data-driven answers. The early days were defined by a relentless dedication to building a comprehensive understanding of hereditary disorders. This wasn't just about analyzing a test tube; it was about meticulously connecting the dots between genetic information, clinical symptoms, and biochemical data to offer a holistic view of a patient's condition. This foundational commitment to in-depth medical expertise, supported by the latest in cutting-edge technology, became the cornerstone of Centogene's identity.

What started as a specialized laboratory has since blossomed into a global leader in the field of precision medicine. The company's evolution has been marked by significant milestones, including the creation of the CENTOGENE Biodatabank, one of the world's largest real-world data repositories for rare and neurodegenerative diseases. This invaluable resource, containing data from over a million individuals across more than 120 countries, has been instrumental in accelerating research and development for new orphan drugs. Centogene's narrative is one of continuous innovation, from pioneering multiomic approaches that integrate various data layers to developing sophisticated bioinformatics solutions like their CentoCloud platform. Today, with a diverse team of specialists from over 50 nations and a network of thousands of physicians worldwide, Centogene continues its quest. It stands as a vital partner for pharmaceutical companies, a trusted resource for clinicians, and, most importantly, a beacon of hope for patients and their families, guiding them toward a future where a diagnosis is not an endpoint, but the beginning of a clear path forward.